Control of hereditary disorders.

Genetics is the study of biological variations, and medical genetics is the study of those variations that result in, or predispose to, disease. Although at first blush these definitions seem straightforward, they are, in fact, quite contrary to the present perceptions of what genetics is all about. To the pediatrician it is about birth defects and syndromes, to the internist it is about arcane metabolic and morphological disorders, and to the US Sur­ geon General it appears to be summed up in his phrase "search and de­ stroy." Screening and antenatal diagnosis of genetic abnormalities are mainly in the province of pediatricians and obstetricians. Patients referred to genetics clinics are usually children with dysmorphic syndromes and developmental abnormalities. This and the likely over-representation of pediatricians among medical geneticists at the medical school may lead to the impression by students and faculty that medical genetics is mainly concerned with developmental defects. This obscures the comprehensive scope of genetics. The genes are a source of differences in structural and metabolic properties that account not only for overt disease but also for predisposition to disease under particular conditions of living. Such observations, as the relationships between human leukocyte antigen (HLA) typing and autoimmune disease, low-density lipoprotein receptor variation and heart attacks, or serum levels of pepsinogen I and peptic ulcer, are a few examples of the many hereditary properties that may be "risk factors" for the diseases of middle and later life (1). The lack of interest among those concerned with preventive medicine is probably related to the preoccupation of medical geneticists with rare con-

[1]  D. Meryash,et al.  Prospective study of early neonatal screening for phenylketonuria. , 1981, The New England journal of medicine.

[2]  G. Tovey SHOULD ANTI-D IMMUNOGLOBULIN BE GIVEN ANTENATALLY? , 1980, The Lancet.

[3]  H. Bickel Phenylketonuria: Past, present, future , 1980, Journal of Inherited Metabolic Disease.

[4]  L. Holmes Genetic Counseling for the Older Pregnant Woman: New Data and Questions , 1978, The New England journal of medicine.

[5]  B. K. Trimble,et al.  The amount of hereditary disease in human populations , 1974, Annals of human genetics.

[6]  J. Littlefield Research on cystic fibrosis. , 1981, The New England journal of medicine.

[7]  A. Hagemeijer,et al.  Partial trisomy 21 , 1977, Human Genetics.

[8]  M. Kaback,et al.  Prenatal diagnosis of hereditary disorders. , 1978, Pediatric clinics of North America.

[9]  J. Stephenson Tay-Sachs Disease: Screening and Prevention , 1979 .

[10]  H. Nadler Antenatal detection of hereditary disorders. , 1968, Pediatrics.

[11]  C. Huether,et al.  Human genetics teaching in U.S. Medical Schools , 1982, Japanese Journal of Human Genetics.

[12]  Terrance E. Swanson ECONOMICS OF MONGOLISM , 1970 .

[13]  J. Erickson Down syndrome, paternal age, maternal age and birth order , 1978, Annals of human genetics.

[14]  C. Laberge,et al.  Population genetics and health care delivery: the Quebec experience. , 1976, Advances in human genetics.

[15]  L. Gibson Screening of newborns for cystic fibrosis. , 1980, American journal of diseases of children.

[16]  P. Mamunes Neonatal screening tests. , 1980, Pediatric clinics of North America.

[17]  A. Read,et al.  POSSIBLE PREVENTION OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATION , 1980, The Lancet.

[18]  Early Diagnosis and Prevention of Genetic Disease , 1979, Annals of clinical biochemistry.

[19]  H. Goodman,et al.  Experimental Isoimmunization to Hemoantigens in Man , 1961, The Journal of Immunology.

[20]  H. Nadler,et al.  Intrauterine detection of cystic fibrosis. , 1980, Pediatrics.

[21]  M. Kramer,et al.  Cord blood screening for sickle hemoglobins: Evidence for female preponderance of hemoglobin S , 1978 .

[22]  R. Howell,et al.  Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia. , 1981, The Journal of pediatrics.

[23]  D. Hardwick,et al.  Use of a dried blood spot in immunoreactive-trypsin assay for detection of cystic fibrosis in infants. , 1981, Clinical chemistry.